StonvexLoading…
StonvexStonvexStonvexCore line items from AIM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $88.00K | $170.00K | $202.00K | $141.00K |
Operating Income | $-11.66M | $-19.77M | $-31.92M | $-19.92M |
Net Income | $-13.96M | $-17.32M | $-28.96M | $-19.45M |
EPS (Diluted) | $-8.62 | $-30.92 | $-0.60 | $-0.40 |
Total Assets | $5.78M | $8.61M | $19.38M | $40.49M |
Total Liabilities | $15.56M | $9.93M | $9.15M | $2.02M |
Cash & Equivalents | $2.98M | $1.70M | $5.44M | $27.05M |
Free Cash Flow OCF − CapEx | Not available | $-14.91M | Not available | $-16.19M |
Shares Outstanding | 3.07M | 655.26K | 49.10M | 48.08M |